Top 14 Molecular Diagnostics Firms
June 2, 2014Xagenic was honored with the 2014 North America Frost & Sullivan Award for New Product Innovation Leadership for its novel automated diagnostic platform. They most recently announced Series B funding and have raised over $30 million since 2012.
More »
First Patient Enrolled in SImmetry Sacroiliac Joint Fusion Clinical Study
May 29, 2014First Patient Enrolled in SImmetry Sacroiliac Joint Fusion Clinical Study
More »
Tragara’s TG02 is Highly Active in CLL Cells Derived from Patients who have Failed Treatment with Ibrutinib
May 28, 2014Tragara Pharmaceuticals announced results of their oral cyclin dependent kinase inhibitor, TG02, from a new preclinical study. TG02 was found to be active in cells derived from chronic lymphocytic leukemia patients who had failed treatment with Ibrutinib.
More »